• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Philips Launches Informatics Platform to Advance Drug Research & Biomarker Discovery

by Fred Pennic 06/19/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Philips Acquires Northern Irish Digital Pathology Startup PathXL

Today, Philips has announced the launch of Xplore, a web-based image and data management platform that will help pharma and academic researchers speed up drug research and biomarker discovery through enhanced integration, visualization and analytics tools. Xplore v4.0 will be available commercially in July 2017. Customers have the option to purchase the basic package or with custom additions including a dedicated TMA module for enabling faster and streamlined research.

As the industry continues to focus heavily on personalized medicine, the pressure is currently on for high speed and quality tissue pathology review and analysis. Computational pathology tools such as Xplore can assist with this process by enhancing researchers’ ability to gather important insights through multi-source data integration. Xplore also allows labs to store clinical, image analysis, molecular and summary genomic data with research pathology whole slide images (WSI) or tissue microarray (TMA) studies, and promotes multi-site collaboration and knowledge sharing among researchers.  Enhanced search capabilities and data mining tools will help researchers quantify disease specific signatures and identify clinically significant cohorts more quickly. The web-based platform allows researchers to connect across institutions for multisite collaboration and knowledge sharing on a global scale. 

The open platform structure of Xplore offers integration with third party image analysis vendors, such as Definiens Tissue Studio® and Indica Halo®. Additionally, researchers have the flexibility to use images from multiple digital pathology scanner vendors, including the high-quality images from the Philips IntelliSite Pathology Solution.

“Delivering on the promise of personalized medicine means that multiple data sources need to be integrated and analyzed,” said Russ Granzow, General Manager of Philips Digital Pathology Solutions. “Computational pathology research tools will be essential to move forward in our increasingly complex medical and research environment.”

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: bioinformatics, Biomarker Discovery, Biomarkers, Digital Pathology, Drug Research, Health Informatics, IntelliSite Pathology Solution, Philips, Precision Medicine

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

The Real Risk in Healthcare AI Isn’t the Model. It’s the Data. 

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |